Madrigal Pharmaceuticals financials at a glance

+ Portfolio

The revenue of Madrigal Pharmaceuticals is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -19.99 Dollars per share in 2023, which was 17.77 lower than 2021. And about -0.32571 billion Dollars are reported as free cash flow in the financials of Madrigal Pharmaceuticals 2023. No dividends were paid to the shareholders of the Madrigal Pharmaceuticals stock NasdaqGS:MDGL in the financial year 2023.

$0.00M

Revenue

$-17.23

Earnings Per Share

0.00%

Gross Margin %

$-,292.52M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-17.23

Gross Margin %

0.00

Free Cash Flow

-,292.52

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016
Rev.	Revenue	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-19.24	$-17.23	$-14.63	$-13.09	$-5.45	$-2.22	$-2.54	$-5.07
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0	0
Sha.	Shares	N/AM	18.14M	17.1M	16.02M	15.43M	15.42M	14.23M	12.17M
OCF	Operating Cash Flow	N/A	$-,224.86M	$-,183.92M	$-,157.56M	$-41.62M	$-25.51M	$-22.32M	$0.00M
FCF	Free Cash Flow	N/A	$-,292.52M	$-,242.29M	$-,157.90M	$-41.80M	$-25.53M	$-22.44M	$0.00M
FCFS	Free Cash Flow Per Share	$-16.80	$-13.13	$-11.14	$-10.22	$-2.71	$-1.73	$-1.83	$-3.38

Madrigal Pharmaceuticals financials at a glance

Financials

Discover